Is Ketamine Addictive? Dependence & Withdrawal Risk

The honest answer is yes: ketamine has a real potential for psychological dependence, and tolerance can develop with heavy, repeated use. It's a Schedule III controlled substance in the US for exactly that reason. What gets lost in a lot of clinic marketing is the second half of the picture — the exposure pattern behind almost everything known about ketamine dependence is frequent, unsupervised, often escalating recreational use, not a short course of monitored treatment. Clinical ketamine protocols exist the way they do specifically to keep patients away from that pattern: screened intake, doses set and given by a clinician, defined start and stop points, and no open supply for self-directed use. This guide covers how dependence actually develops, what a legitimate clinic does differently, the warning signs worth knowing, and the questions worth asking before you start treatment.

How Ketamine Dependence Develops

Most of what's documented about ketamine dependence comes from people using it recreationally — often to chase the dissociative "K-hole" effect at doses well above anything a clinic would give, and often daily or near-daily over months or years. In that pattern, two things tend to show up together. The first is tolerance: needing a larger dose over time to get the same effect, which pushes use higher and more frequent. The second is psychological dependence — a learned pull toward the drug's effect as a way to cope, escape, or self-soothe, strong enough that stopping feels difficult even when the person recognizes it's causing problems.

Ketamine doesn't produce the same kind of severe physical dependence associated with opioids or alcohol, where the body itself adapts to the drug's presence and stopping triggers a dangerous physical reaction. Its dependence risk sits more in the psychological and behavioral category — which doesn't make it minor, but does make it a different problem to screen for and manage than opioid dependence. (For more on how ketamine differs from opioids pharmacologically and legally, see is ketamine an opioid.) The dose, frequency, and setting all matter — which is the whole argument for why clinical treatment looks nothing like recreational use in practice.

Is Ketamine Addictive in a Clinical Setting?

The pharmacology doesn't change once you walk into a clinic — the same molecule carries the same underlying misuse potential. What changes is the exposure pattern. Clinical ketamine treatment for depression, anxiety, PTSD, or pain typically follows a defined induction series (often around six sessions over two to three weeks) followed by occasional booster sessions, spaced out and reassessed by a prescriber rather than repeated indefinitely or on demand. Doses are set by a clinician based on weight and response, not chosen by the patient, and for IV or IM treatment the medication is given and stays at the clinic — there's no vial going home with you. That structure removes most of the conditions — frequent access, escalating self-directed dosing, no oversight — that drive the recreational-use pattern described above.

This article focuses specifically on dependence and misuse risk. For the broader picture of ketamine therapy's side effects, contraindications, and monitoring standards, see our guide to whether ketamine therapy is safe.

How Clinics Structure Treatment to Manage the Risk

A clinic that takes dependence risk seriously builds several safeguards into how it delivers treatment, not just what it says in an intake form:

• Screening for substance use history. Intake should ask about your personal and family history with substance use disorders, since that history is relevant to how closely you may need to be monitored — not necessarily a reason to rule out treatment on its own.
• Clinician-controlled dosing. The dose and schedule are set by a prescriber based on your diagnosis and response, not left open for you to adjust or request more of.
• In-clinic administration for IV and IM protocols. The medication is given on-site and stays there — most clinics do not send ketamine home with patients receiving infusions or injections.
• Limited, monitored quantities for at-home oral programs. Where oral ketamine or troches are prescribed for home use, legitimate telehealth programs dispense small, defined quantities with regular check-ins rather than large supplies for open-ended self-administration.
• A defined course with reassessment points. Booster sessions are reviewed and re-approved periodically rather than continuing by default — a sign the clinic is tracking your ongoing need, not just repeat billing.
• DEA-registered prescribing.As a Schedule III drug, ketamine can only be prescribed by a clinician with active DEA registration, which creates a paper trail and accountability that unregulated sources don't have.

The same course of treatment, over time, is also the one to watch for a different kind of long-term risk — cumulative physical effects from repeated dosing, separate from dependence. See long-term effects of ketamine therapy for what's documented there.

Spravato and the REMS Program

Spravato (esketamine nasal spray) is the clearest example of a misuse-potential safeguard built directly into a drug's approval. Because the FDA recognized esketamine's dependence risk when it approved the medication, Spravato can only be dispensed and given through the Risk Evaluation and Mitigation Strategy — REMS — program. In practice, that means the medication is shipped only to REMS-certified treatment centers, never to a pharmacy for a patient to pick up or to a patient's home. You self-administer the spray in the clinic under a clinician's direct observation, then stay for a mandatory monitoring period, typically around two hours, before you're cleared to leave with someone else driving. There is no legitimate way to obtain take-home Spravato, which closes off the unsupervised-access pathway that's behind most documented ketamine misuse.

Warning Signs of Problematic Ketamine Use

Even inside a structured treatment relationship, it's worth knowing what a developing problem can look like:

• Wanting or requesting sessions more often than your prescriber has scheduled.
• Craving the dissociative effect between appointments, not just noticing relief from your underlying symptoms.
• Using ketamine — or thinking about using it — to cope with ordinary stress rather than as part of a defined treatment course.
• Needing a higher dose over time to feel the same effect (tolerance).
• Seeking ketamine from a source outside your licensed clinical relationship.
• Noticing strain on work, relationships, sleep, or finances that traces back to use.
• Feeling irritable, low, or anxious between sessions in a way that only using again seems to relieve.

If you stop or taper after a period of frequent use, some discomfort during the adjustment is common. What that can look like, and how long it tends to last, is covered in ketamine withdrawal symptoms. None of these signs mean treatment has failed or that you did something wrong — they're a reason to talk to your prescriber, not a reason to hide what's happening. If you're worried about your own or someone else's substance use more broadly, the SAMHSA National Helpline (1-800-662-4357) is a free, confidential, 24/7 resource.

Can Ketamine Treat Addiction to Other Substances?

It sounds contradictory, but researchers are actively studying ketamine-assisted therapy as a treatment for alcohol use disorder and other substance use disorders, usually delivered alongside psychotherapy in a research or specialty clinical setting. A drug having its own misuse potential and also showing promise, under tightly controlled conditions, for treating a different addiction aren't mutually exclusive facts — both can be true at once, the same way some medications with dependence risk of their own are still used to manage withdrawal from other substances. This use is still investigational for many indications and isn't something to pursue outside a licensed research or treatment program. If you're considering it, ask a prescriber directly about the evidence for your specific situation rather than relying on a clinic's marketing claims.

Rehab and Recovery from Ketamine Misuse

For the smaller group of people who develop a genuine problem with ketamine — almost always tied to frequent, unsupervised, or recreational use rather than monitored treatment — recovery generally starts the same way it does for other substance use disorders: an evaluation by a substance use treatment provider, a plan for tapering safely if physical or psychological withdrawal is a concern, and ongoing support such as counseling or a structured program. Because ketamine's dependence pattern is mostly psychological rather than acutely dangerous to stop, outpatient treatment is often appropriate, though anyone with a heavier use history should have that decision made by a clinician rather than deciding alone. Recovery from ketamine misuse looks similar to recovery from other substance use disorders — it's treatable, and asking for help early tends to make it more straightforward, not less.

Questions to Ask a Ketamine Clinic Before Starting Treatment

• How do you screen for a personal or family history of substance use disorders?
• Who sets the treatment schedule, and how do you decide whether to extend or repeat booster sessions?
• Do you ever dispense take-home doses? If so, how are quantities limited and monitored?
• What does follow-up look like between sessions, and how would you flag a developing problem?
• For Spravato: can you confirm your REMS certification?

A clinic that answers these clearly, without hesitation, is telling you something about how seriously it takes this risk. For a broader checklist on confirming licensure and credentials before you book, see how to verify a ketamine provider. When you're ready to compare options, browse ketamine clinics near you and ask each one these questions directly.

Frequently Asked Questions

None of this is meant to talk you into or out of treatment — it's meant to give you a realistic picture so you can have an informed conversation with a licensed clinician about your own history and risk.

Sources: DEA controlled substance scheduling for ketamine, FDA prescribing information and REMS program requirements for Spravato (esketamine), and published clinical and case-series literature on ketamine dependence, tolerance, and misuse patterns. Informational only — not medical advice. If you're concerned about your own or someone else's substance use, talk to a licensed clinician or contact the SAMHSA National Helpline at 1-800-662-4357.